Moomoo AIのまとめ
SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.
SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.
SeaStar Medical Holding Corporation（SeaStar Medical）は、2024年8月16日に証券取引委員会（SEC）に対してフォームS-3の修正を申請しました。この修正は、売却証券保有者による最大1,014,219株の普通株式の公募に関する1933年証券法に基づく登録声明書に関連しています。これらの株式は、SeaStar Medicalが発行した特定のwarrantの行使に関連しています。同社は、売却証券保有者による株式売却から得られた収益を受け取りませんが、warrantがキャッシュレスベースで行使されない限り、warrantの行使価格を受け取ります。売...すべて展開
SeaStar Medical Holding Corporation（SeaStar Medical）は、2024年8月16日に証券取引委員会（SEC）に対してフォームS-3の修正を申請しました。この修正は、売却証券保有者による最大1,014,219株の普通株式の公募に関する1933年証券法に基づく登録声明書に関連しています。これらの株式は、SeaStar Medicalが発行した特定のwarrantの行使に関連しています。同社は、売却証券保有者による株式売却から得られた収益を受け取りませんが、warrantがキャッシュレスベースで行使されない限り、warrantの行使価格を受け取ります。売却証券保有者は、取引所、店頭市場、またはプライベート取引を通じて株式を売却することができます。同社は、株式の登録に関連する費用を負担することを承諾しており、その費用は45,750ドルと見積もられています。登録により、売却証券保有者は、目論見書の日付以降、いつでも株式を売却することができ、公募はSECの規則や規制を含む様々な条件に従うことになります。
役に立った
役に立たない
